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Abstract The tyrosine phosphatase r-PTPR is able to suppress
the malignant phenotype of rat thyroid tumorigenic cell lines. To
identify r-PTPR interacting proteins, a yeast two-hybrid screen-
ing was performed and an insert corresponding to the full-length
syntenin cDNA was isolated. It encodes a protein containing two
PDZ domains that mediates the binding of syntenin to proteins
such as syndecan, proTGF-K, L-ephrins and neurofascin. We
show that r-PTPR is able to interact with syntenin also in
mammalian cells, and although syntenin is a tyrosine-phosphory-
lated protein it is not a substrate of r-PTPR. The integrity of
both PDZ domains of syntenin and the carboxy-terminal region
of r-PTPR are required for the interaction between syntenin and
r-PTPR. ß 2001 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
The r-PTPR gene encoding a receptor type tyrosine phos-
phatase was isolated by our group from a normal rat thyroid
cell line, PC Cl 3 [1]. The r-PTPR protein contains a unique
intracellular catalytic domain, a short transmembrane do-
main, and an extracellular region containing eight ¢bronectin
type III-like repeats. Its expression is positively regulated by
thyrotropin through the protein kinase A pathway, and is
negatively regulated by protein kinase C activation [2]. More-
over, r-PTPR gene expression is reduced in several thyroid
oncogene-transformed cells, and absent in highly malignant
thyroid cells [1]. The expression of its human homolog,
DEP-1/HPTPR, is increased in dense cell culture in compar-
ison to sparse cell culture [3]. DEP-1/HPTPR plays a relevant
role in signal transduction of activated T lymphocytes [4,5]
and it is associated to memory of B lymphocytes [6]. The
mouse homolog of r-PTPR induces terminal di¡erentiation
in erythroleukemia cells [7].
A possible role of this phosphatase as a tumor suppressor
has been recently envisaged by our group. We demonstrated a
dramatic reduction of DEP-1/HPTPR in human thyroid car-
cinomas compared to normal thyroid tissues and that the
transfection of r-PTPR gene in tumorigenic rat thyroid cells
suppresses the malignant phenotype. Tumor suppressor activ-
ity of r-PTPR is mediated by p27Kip1 protein stabilization,
through the inhibition of mitogen-activated protein kinase
activation [8]. These observations indicate a role of r-PTPR
in signal transduction processes that promote malignant
growth suppression and cell di¡erentiation. However, the cel-
lular pathways in which r-PTPR is involved still need to be
de¢ned. Therefore, the search for proteins interacting with r-
PTPR may represent an important tool for the de¢nition of its
biological functions. Some DEP-1/HPTPR interacting proteins
were detected by co-precipitation and in vitro binding experi-
ments; one of them was identi¢ed as a 64 kDa serine/threo-
nine kinase, but the functional role of this interaction was not
investigated [9]. Recently, it has been demonstrated that DEP-
1/HPTPR is able to de-phosphorylate PDGFL receptor at site-
speci¢c tyrosines [10].
To identify molecular partners of r-PTPR, we have per-
formed a two-hybrid screening. Here, we demonstrate that
r-PTPR is able to interact with syntenin, ¢rstly described as
a syndecan binding protein [11]. Syntenin contains two PDZ
(PSD-95, Dlg, ZO-1) domains, which are protein recognition
modules that bind speci¢c peptides on target proteins [12].
PDZ family proteins are involved in protein targeting on
the inner surface of the plasma membrane and in assembly
of multiprotein complexes [13]. We show that the r-PTPR
binds with its carboxy-terminal region to the PDZ domains
of syntenin.
2. Materials and methods
2.1. Yeast two-hybrid screening
The intracellular gene fragment of C1118S mutant of r-PTPR was
ampli¢ed by PCR with Pfu polymerase (Stratagene) and cloned in
frame at EcoRI and PstI restriction sites of the pBridge vector (Clon-
tech). Yeast strain PJ69-2A (Clontech) was transformed with the
pBridge-PTPR recombinant vector and mated following the manufac-
turer’s instructions with the strain Y187 pretransformed with a HeLa
cDNA library cloned in pGADGH vector (Clontech). Positive clones
were selected on quadruple drop-out agar plates (3Leu, 3Trp, 3His,
3Ade) and assayed for L-galactosidase activity. To assess the specif-
icity of the interaction, positive library recombinant vectors were used
to co-transform PJ69-2A with pBridge-PTPR, pBridge empty vector
or pBridge-HMGI(Y) (a recombinant pBridge vector in which the
full-length of high mobility group I-Y protein was cloned). Trans-
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formants were plated on double drop-out agar plates. At least ¢ve co-
transformed colonies for each transformation were streaked on quad-
ruple drop-out agar plates and yeast growth was controlled after
2 days. The cDNA inserts from the speci¢c clones were sequenced
using the dideoxy termination method.
Mutant forms of r-PTPR intracellular region and syntenin were
generated by PCR with Pfu polymerase. All constructs containing r-
PTPR and syntenin mutant forms were sequenced to con¢rm the
correct synthesis.
Interaction assay with mutant gene forms was performed by co-
transformation of PJ69-2A followed by growth veri¢cation of trans-
formants in quadruple drop-out agar plates.
2.2. Expression vectors
Full-length sequence of r-PTPR was subcloned at an EcoRI site of
pcDNA3 expression vector (Invitrogen). A mutant form of r-PTPR,
lacking the last four amino acids, was generated by PCR and sub-
cloned at EcoRI and SalI of pcDNA3.
The pHA-tagged syntenin was generated by PCR ampli¢cation of
the full-length of syntenin. The PCR fragment was cloned into an
EcoRI site, blunted by Klenow polymerase, of pCEFL-HA mamma-
lian expression vector. All recombinant constructs were sequenced to
con¢rm the correct synthesis.
2.3. Antibodies and immunoprecipitations
Antibodies used were: polyclonal rabbit antibodies generated
against a DEP-1 peptide [9], polyclonal rabbit antibodies generated
against the intracellular region of r-PTPR fused to GST [8], anti-HA
antibodies (Roche) and anti-phosphotyrosine (anti-pTyr) antibodies
(Santa Cruz Biotechnology).
HEK 293T cells were grown in Dulbecco’s modi¢ed Eagle’s me-
dium supplemented with 10% fetal bovine serum and transfected by
the calcium phosphate method. Cells were lysed 48 h after transfection
in a bu¡er (1% Nonidet P-40, 50 mM Tris^HCl, 150 mM NaCl) with
complete protease inhibitors (Roche) and 1 mM sodium vanadate.
Proteins were quanti¢ed by a modi¢ed Bradford assay (Bio-Rad).
500 Wg of proteins were subjected to immunoprecipitation with 5 Wg
of anti-DEP-1 or 2 Wg of anti-HA antibodies and 40 Wl of protein A-
agarose (Roche). Immunoprecipitates were washed three times in
HNTG bu¡er (20 mM HEPES, pH 7.5, 10% glycerol, 0.1% Triton
X-100, 150 mM NaCl). Proteins were separated by SDS^PAGE and
transferred to Immobilon-P membrane (Millipore). The ¢lter was in-
cubated with the appropriate antibody and the detection of proteins
was performed with the enhanced chemiluminescence system (Amer-
sham).
3. Results
3.1. Two-hybrid screening of r-PTPR interacting proteins:
isolation of the syntenin gene
In order to identify the proteins that associate with r-PTPR
protein, we performed a two-hybrid screening of a cDNA
HeLa library using the cytoplasmic region of r-PTPR as a
bait. The sequence of three positive clones revealed that
they contained identical inserts corresponding to the full-
length of syntenin cDNA. Speci¢city of the interaction be-
tween r-PTPR and syntenin was con¢rmed by two-hybrid as-
say as described in Section 2.
Syntenin is a 32 kDa protein containing an amino-terminal
region rich in serines, threonines and tyrosines and a carboxy-
terminal region with two PDZ domains which are protein^
protein interaction modules [12,13]. Syntenin has been iso-
lated as a syndecan binding protein [11] ; afterwards, its inter-
action with class B ephrins, proTGF-K, neurexin and neuro-
fascin has been demonstrated [14^17]. Transcriptional
induction of syntenin was observed in human umbilical arte-
rial endothelial cells stimulated with tumor necrosis factor
[18]. Recently, the rat homolog of syntenin human gene has
been cloned. Rat syntenin protein shows 91% identity with
human syntenin [17].
3.2. Mapping of r-PTPR^syntenin interaction
To de¢ne the minimal regions required for syntenin^r-PTPR
interaction, deletion constructs of r-PTPR and syntenin were
generated and used in two-hybrid assays. All the previously
described molecular partners associate with syntenin only if
both syntenin’s PDZ domains are present [14^17]. Moreover,
the binding occurs by the carboxy-terminal regions of synte-
nin interacting proteins. These regions possess characteristic
peptides de¢ned as PDZ binding peptides and essential for the
interaction with the proteins containing PDZ domains [12].
As shown in Fig. 1A, also for the interaction with r-PTPR,
both PDZ domains of syntenin are required. The intracellular
region of r-PTPR is able to bind the PDZ containing region
but not the N-terminal region of syntenin. Furthermore, syn-
tenin interacts with the C-terminal region but not with the
juxtamembrane region of r-PTPR (Fig. 1B). These results sug-
gest that the carboxy-terminal region of r-PTPR contains a
PDZ binding peptide. Consistently, r-PTPR has an alanine
at position 0 and a tyrosine at position 32; these amino acids
confer the features of binding site for PDZ domains to the
carboxy-terminal peptide of r-PTPR, as assessed in previous
studies [12]. Thus, we made a mutant bait containing the
cytoplasmic r-PTPR region deleted of the C-terminal four
amino acids. This bait fails to interact with syntenin in a
two-hybrid assay. In addition, a bait containing the C-termi-
Fig. 1. Mapping of the interaction domains of syntenin and r-PTPR
by yeast two-hybrid assay. Interactions were scored as growth of
co-transformants on 3Ade and 3His plates. A: Full-length and dif-
ferent deleted versions of syntenin fused with a GAL4 activation
domain were co-transformed with a vector containing the intracellu-
lar region of r-PTPR fused to a GAL4 binding domain (pBridge-r-
PTPR). B: The intracellular region and di¡erent deleted versions of
r-PTPR fused with a GAL4 binding domain were co-transformed
with a vector containing the full-length of syntenin fused to a
GAL4 activation domain (pGADGH-syntenin). Ellipses represent
the N-terminal region of syntenin, open boxes represent the PDZ
domains of syntenin, dashed boxes represent the catalytic domain of
r-PTPR and the GYIA is the C-terminal sequence of r-PTPR.
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nal 30 amino acids of r-PTPR (lacking the catalytic domain) is
still able to interact with syntenin.
3.3. Immunoprecipitation studies
Co-immunoprecipitation experiments were performed to in-
vestigate whether r-PTPR is able to interact in mammalian
cells with syntenin. HEK 293T cells were co-transfected with
the full-length of the r-PTPR gene or the r-PTPR gene deleted
of the last four codons (r-PTPRv4) and the full-length synte-
nin cDNA tagged with an HA epitope. Subsequently, cell
lysates were immunoprecipitated with the antibodies raised
versus the extracellular region of the phosphatase. The immu-
noprecipitates were then immunoblotted and hybridized with
an anti-HA antibody. As shown in Fig. 2, co-immunoprecipi-
tation was observed with r-PTPR full-length but not with r-
PTPRv4, indicating that also in mammalian cells r-PTPR as-
sociates with syntenin and that the interaction depends on the
phosphatase C-terminal region.
We then tried to demonstrate a possible role of r-PTPR in
the regulation of syntenin activity. Human syntenin, in the
amino-terminal region, has ¢ve tyrosines that may represent
a potential target for tyrosine kinases. To investigate whether
syntenin is a tyrosine-phosphorylated protein, we transfected
HA-syntenin in HEK 293T and immunoprecipitated the cell
lysates with anti-HA antibodies. The immunoprecipitates were
blotted and hybridized with anti-pTyr antibodies. As shown in
Fig. 3A, syntenin is a tyrosine-phosphorylated protein. We
then checked whether tyrosine phosphorylation of syntenin
was a¡ected by the over-expression of r-PTPR and we found
that in HEK 293T cells, the expression of r-PTPR is not able
to reduce tyrosine phosphorylation levels of syntenin (Fig.
3A). The phosphatase activity was intact as assessed by com-
paring the pattern of phosphorylated proteins in cells trans-
fected or not with r-PTPR ([8] and data not shown). This
result seems to exclude syntenin as a substrate of r-PTPR.
In order to investigate whether r-PTPR binds the phosphor-
ylated or the unphosphorylated form of syntenin, we co-trans-
fected HEK 293T cells with HA-syntenin or pCEFL-HA
empty vector and r-PTPR expression vector. We performed
an immunoprecipitation with speci¢c antibodies against the
extracellular region of r-PTPR. The immunoprecipitated pro-
teins were blotted and incubated with anti-pTyr antibodies. At
the molecular weight corresponding to that of syntenin, a very
weak tyrosine-phosphorylated band was detected in the im-
munoprecipitated sample containing HA-syntenin (Fig. 3B).
In contrast, the incubation with anti-HA antibodies showed
an intense band corresponding to the syntenin protein (Fig.
3B). These data suggest that r-PTPR interacts preferentially
with the unphosphorylated form of syntenin.
4. Discussion
In this study we provide evidences that the r-PTPR phos-
phatase associates with syntenin, a protein containing two
PDZ domains. By using the two-hybrid system we showed
that syntenin binding occurs at the carboxy-terminus of
Fig. 2. HEK 293T cells were transfected with the expression vectors
indicated. Cell lysates were immunoprecipitated with anti-DEP anti-
bodies that recognize the extracellular region of r-PTPR. Cell lysates
and immunoprecipitates (IP) were blotted and then hybridized with
antibodies speci¢c for the intracellular region of r-PTPR or HA epi-
tope.
Fig. 3. A: HEK 293T cells were transfected with pCEFL-HA-syntenin in the presence of pcDNA3 vector or pcDNA3-r-PTPR. Cell lysates
were immunoprecipitated with anti-HA antibodies, blotted and then hybridized with anti-HA or anti-pTyr antibodies. Cell lysates were blotted
and then incubated with anti-r-PTPR antibodies to demonstrate the phosphatase over-expression. B: HEK 293T cells were transfected with
pcDNA3-r-PTPR in the presence of pCEFL-HA empty vector or pCEFL-HA-syntenin. Cell lysates were immunoprecipitated with anti-DEP
antibodies, blotted, and then incubated with anti-pTyr or anti-HA or anti-r-PTPR antibodies.
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r-PTPR protein. Both PDZ domains of syntenin are required
for the interaction. In other studies it has been demonstrated
[14^17] that the binding of syntenin to its molecular partners
depends on the integrity of both PDZ domains.
The carboxy-terminus of r-PTPR belongs to the class II
PDZ binding peptides because it contains an aromatic amino
acid (tyrosine) at the 32 position and an hydrophobic amino
acid (alanine) at the 0 position [12]. Deletion of the four
carboxy-terminal amino acids abolishes r-PTPR binding to
syntenin. In addition, to further con¢rm the speci¢city of
the interaction and to demonstrate that it is independent
from phosphatase catalytic domain, we found that the C-ter-
minal 30 amino acidic region of r-PTPR is still able to interact
with syntenin. Deletion of the N-terminal region of syntenin
does not impair r-PTPR interaction with syntenin. This ¢nd-
ing is in accordance with the presence of a PDZ class II
carboxy-terminal peptide in r-PTPR. In fact, the presence of
the N-terminal region of syntenin does not in£uence the in-
teraction with all syntenin interacting proteins belonging to
the PDZ class II such as ephrin B2, syndecan and neurexin
[11,14,17].
Co-immunoprecipitation studies con¢rmed that the interac-
tion between r-PTPR and syntenin depends on the carboxy-
terminal region of r-PTPR. Interestingly, the C-terminal four
amino acids of r-PTPR are identical to those of human PTPR,
suggesting that the interaction with syntenin could occur also
in humans. Moreover, we found that syntenin is a tyrosine-
phosphorylated protein, but the over-expression of r-PTPR
does not modify tyrosine phosphorylation levels of syntenin.
These ¢ndings indicated that syntenin is not a substrate of r-
PTPR. Moreover, we found that r-PTPR binds preferentially
the unphosphorylated form of syntenin, and this could explain
the inability of r-PTPR to decrease the phosphorylation level
of syntenin.
In this study, we analyzed the molecular aspects of the
interaction between r-PTPR and syntenin. Since syntenin is
not a substrate of r-PTPR, it is hard to speculate a regulatory
activity of r-PTPR on it. On the other hand, syntenin could
regulate r-PTPR activity in di¡erent ways according to its
established functions. Syntenin may transport and position
r-PTPR in the cell as occurs for proTGF-K [15], and in light
of the syntenin localization either in plasma membrane or in
intracellular vesicular compartment [19]. Alternatively, synte-
nin may enhance r-PTPR action recruiting other syntenin
binding proteins as substrates, because syntenin can interact
simultaneously with two PDZ binding peptides [16] or dimer-
ize forming complexes that contained di¡erent proteins [17].
Therefore, modulation of r-PTPR activity by syntenin may be
important in the inhibition of the transformed cell growth
mediated by r-PTPR.
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